OZANIMOD AS A MAINTENANCE THERAPY IN ADVANCED THERAPY–NAIVE ULCERATIVE COLITIS PATIENTS WITH MODERATE VS SEVERE ENDOSCOPIC DISEASE

Britta Siegmund  ¹     Peter Irving  ²     Geert D’Haens  ³     Corey A. Siegel  ⁴     Anjali Jain  ⁵     Hsiuanlin Wu  ⁵     Mark Osterman  ⁵     David T. Rubin  ⁶     Millie Long  ^7    
1 Charité – Universitätsmedizin Berlin, Berlin, Germany
² Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
³ Amsterdam University Medical Center, Amsterdam, Netherlands
⁴ Dartmouth-Hitchcock Medical Center, Lebanon, United States
⁵ Bristol Myers Squibb, Princeton, United States
⁶ University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States
⁷ UNC Chapel Hill, Chapel Hill, United States

Topic
IBD

Session
Traffic control in IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)